Afinion gathers momentum as Axis-Shield moves into profitability for the first time
This article was originally published in Clinica
Axis-Shield has enlisted long-time partner Abbott Labs as exclusive US distributor of Afinion, its multi-test point-of-care (POC) analyser. The Anglo-Norwegian company received US FDA clearance for its system and HbA1c diabetes test - the first test approved for use on the analyser - in July this year (see Clinica No 1168, p 22).
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.